Recombinant Zebrafish ALDH7A1
Cat.No. : | ALDH7A1-11996Z |
Product Overview : | Recombinant Zebrafish ALDH7A1 full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Zebrafish |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC. |
Storage Buffer : | PBS buffer |
Gene Name : | aldh7a1 aldehyde dehydrogenase 7 family, member A1 [ Danio rerio (zebrafish) ] |
Official Symbol : | ALDH7A1 |
Gene ID : | 334197 |
mRNA Refseq : | NM_212724 |
Protein Refseq : | NP_997889 |
UniProt ID : | Q803R9 |
Products Types
◆ Recombinant Protein | ||
Aldh7a1-481M | Recombinant Mouse Aldh7a1 Protein, MYC/DDK-tagged | +Inquiry |
ALDH7A1-459M | Recombinant Mouse ALDH7A1 Protein, His (Fc)-Avi-tagged | +Inquiry |
ALDH7A1-279R | Recombinant Rat ALDH7A1 Protein, His (Fc)-Avi-tagged | +Inquiry |
ALDH7A1-0391H | Recombinant Human ALDH7A1 Protein (Met1-Gln539), N-His-tagged | +Inquiry |
ALDH7A1-623R | Recombinant Rat ALDH7A1 Protein | +Inquiry |
◆ Lysates | ||
ALDH7A1-8915HCL | Recombinant Human ALDH7A1 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (14)
Ask a questionYes, ALDH7A1 deficiency can be diagnosed through genetic testing. Genetic testing can identify mutations in the ALDH7A1 gene, confirming the diagnosis of this condition. It is typically recommended to perform genetic testing for individuals with clinical signs and symptoms consistent with pyridoxine-dependent epilepsy.
Yes, researchers continue to investigate ALDH7A1 protein and its role in lysine metabolism, pyridoxine-dependent epilepsy, and other related disorders. Some studies focus on understanding the molecular mechanisms underlying ALDH7A1 deficiency and developing potential therapies for affected individuals.
ALDH7A1 protein is known to interact with certain proteins, such as DPC4/SMAD4 and SP1 transcription factor. These interactions may play a role in the regulation of gene expression and cellular processes.
ALDH7A1 protein has also been reported to be involved in the metabolism of pipecolic acid, which is derived from lysine and is important for the biosynthesis of neurotransmitters and the regulation of fatty acid metabolism.
There are no specific dietary recommendations solely for ALDH7A1 deficiency. However, as with any seizure disorder, it is generally recommended for individuals to follow a well-balanced diet and avoid triggers that may worsen seizures, such as excessive caffeine or alcohol consumption.
ALDH7A1 protein participates in the lysine degradation pathway.
Yes, the main treatment for pyridoxine-dependent epilepsy caused by ALDH7A1 deficiency is the administration of pyridoxine (vitamin B6) supplements. This treatment helps to bypass the metabolic pathway that is disrupted due to the ALDH7A1 deficiency and can effectively control seizures in most individuals with this condition. In some cases, additional medications may be prescribed to further manage the seizures.
The ALDH7A1 gene, which encodes the ALDH7A1 protein, is located on chromosome 5q31.3. Mutations in this gene can lead to the deficiency of ALDH7A1 protein, causing pyridoxine-dependent epilepsy.
The regulation of ALDH7A1 protein is not fully understood. However, studies suggest that its expression can be influenced by several factors, including hormonal signals, nutrient availability, and genetic variations.
ALDH7A1 deficiency itself is not considered a progressive disorder. However, if left untreated, the seizures associated with this condition can lead to developmental delays and intellectual disabilities. With early diagnosis and appropriate treatment, the prognosis for individuals with ALDH7A1 deficiency can be improved.
Yes, the ALDH7A1 protein is found in various tissues, including the brain, liver, kidney, and other organs. However, its expression levels may vary among tissues.
Yes, there are support groups and resources available for individuals and families affected by ALDH7A1 deficiency. Organizations such as the Pyridoxine-Dependent Epilepsy Family Association provide support, information, and resources for affected individuals and their families. Medical professionals can also provide guidance and connect individuals with the relevant support networks.
In addition to pyridoxine-dependent epilepsy, mutations in the ALDH7A1 gene can also cause a rare inherited disorder known as hyperlysinemia type 2. This condition is characterized by high levels of lysine in the blood, urine, and tissues.
Deficiency of ALDH7A1 protein results in a rare metabolic disorder called pyridoxine-dependent epilepsy (PDE). This disorder is characterized by seizures that are unresponsive to conventional anti-seizure medications but can be controlled with the administration of vitamin B6 (pyridoxine) or its active form pyridoxal-5'-phosphate.
Customer Reviews (3)
Write a reviewI highly recommend the ALDH7A1 Protein to fellow researchers seeking a high-quality protein that not only meets their experimental requirements but is also accompanied by exceptional technical support.
The ALDH7A1 Protein's consistent stability and robust performance make it an indispensable tool for studying its multifaceted roles and mechanisms within vital biochemical pathways and cellular processes.
What truly distinguishes the ALDH7A1 Protein is the unparalleled technical support provided by the manufacturer.
Ask a Question for All ALDH7A1 Products
Required fields are marked with *
My Review for All ALDH7A1 Products
Required fields are marked with *
Inquiry Basket